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OBJECTIVES We sought to determine the underlying coronary anatomy and characterize the culprit lesion
after non–Q-wave myocardial infarction (NQWMI).
BACKGROUND Although the culprit lesion and infarct-related artery often are easily identified with coronary
angiography after Q-wave MI, the culprit lesion after NQWMI has not been well
characterized. Small retrospective studies have suggested that the absence of Q-waves on an
electrocardiogram is due to incomplete occlusion of the infarct-related artery.
METHODS Coronary angiograms from 350 patients randomized to the early invasive strategy in the
Veterans Affairs Non–Q-Wave Infarction Strategies in-Hospital (VANQWISH) trial were
systematically analyzed in an angiographic core laboratory. A consensus panel identified the
culprit lesion and the infarct-related artery using prespecified criteria for complex lesion
morphology and acute versus chronic occlusions. Severity of angiographic disease and left
ventricular function also were analyzed. Patients with a single identified culprit lesion were
compared with those who had multiple apparent culprits and those without an identifiable
culprit lesion.
RESULTS A single culprit lesion was identified in only 49% of patients undergoing early angiography
after NQWMI. The majority of patients either had no identifiable culprit (37%) or multiple
apparent culprit lesions (14%). A single incomplete occlusion of the infarct-related artery was
found in only 36% of patients, and an isolated acute occlusion of the infarct-related artery
occurred in 13%. Patients without an identifiable culprit lesion had severe coronary disease
(obstructive coronary artery disease [CAD] in 84%) but no complex lesion morphology.
There was no difference in angiographic severity of disease comparing patients with and
without identifiable culprit lesions. Patients with a single incomplete occlusion of the
infarct-related artery were more likely to undergo percutaneous transluminal coronary
angioplasty than other patients, whereas patients with multiple culprit lesions were more
frequently treated with coronary artery bypass grafting.
CONCLUSIONS Coronary angiography early after NQWMI frequently identifies severe obstructive CAD, but
a single identifiable culprit lesion was identified in 50% of patients. Multiple culprit lesions
were seen in 14% of patients. An angiographic culprit lesion could not be identified in more
than one-third of patients undergoing coronary angiography as part of an invasive
strategy. (J Am Coll Cardiol 2002;39:1456–63) © 2002 by the American College of
Cardiology Foundation
The culprit lesion in Q-wave myocardial infarction (MI) is
an acute occlusion of a major epicardial vessel easily visual-
ized angiographically (1). Culprit lesions in Q-wave MI are
See page 1464
the target of treatment with thrombolytic therapy or pri-
mary percutaneous transluminal coronary angioplasty (2–9).
These lesions are located at the site of a ruptured athero-
sclerotic plaque (10,11). In contrast, the culprit lesion in
non–Q-wave MI (NQWMI) is not well characterized. The
few retrospective angiographic studies of patients after
NQWMI have suggested that the infarction is associated
with incomplete occlusion of the infarct-related artery
(12–14). One of the primary reasons for performing angiog-
raphy early after MI is to identify the culprit lesion and
assess the infarct-related arteries’ suitability for revascular-
ization. The purpose of our study was twofold: 1) to
determine how frequently a culprit lesion can be identified
as the cause of the MI in patients with NQWMI, and 2) to
characterize the coronary anatomy in patients with and
without an identifiable culprit lesion.
We separated patients into two groups: those with an
identifiable culprit lesion (complex stenosis or acute occlu-
sion) and those without an identifiable culprit lesion. Pa-
tients with an identifiable culprit lesion were defined as
having incomplete occlusion of the infarct-related artery and
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complex lesion morphology (acute culprit lesions) or acute
occlusion of the infarct-related artery (plaque rupture with
occlusive thrombus). Patients without an identifiable culprit
lesion were found to have obstructive coronary disease of
varying severity but no complex lesion morphology, non-
obstructive coronary artery disease (CAD) or angiographi-
cally normal coronary arteries.
The Veterans Affairs Non–Q-Wave Infarction Strategies
in-Hospital (VANQWISH) trial is the largest prospective,
multicenter randomized study yet undertaken of NQWMI.
Its primary objective was to compare effects of an early
invasive versus non-invasive management strategy on long-
term clinical outcome (death or MI) after NQWMI. In this
study we sought to identify, angiographically, the cause of
the documented NQWMI in patients randomized to the
routine early invasive strategy.
METHODS
The protocol design, baseline characteristics and primary
outcome data are published in detail elsewhere (15,16).
Data reported here are from patients randomly assigned to
the early invasive management strategy who had protocol-
mandated coronary angiography and core laboratory read-
ings. Briefly, patients were eligible if they met all the
following criteria: clinical presentation of evolving acute MI,
MB-CK isoenzyme 1.5 times upper normal limit and no
new Q-waves on serial electrocardiograms (ECGs). Reasons
for exclusion from the trial were cardiogenic shock, severe
heart failure, persistent or recurrent ischemia at rest or
ventricular tachyarrhythmias.
Coronary angiography. All coronary angiograms were
done on-site within three to seven days of NQWMI using
standard techniques and were recorded on 35-mm cine film.
Films were reviewed on-site for clinical decision-making
and subsequently sent to an angiographic core lab, where
they were read by a panel of experienced angiographers.
This report concerns the angiographic core lab data. The
core lab readers and technical personnel were blind to all
clinical and site data. Angiograms were analyzed qualita-
tively by a consensus panel. The films were first given an
overall quality score of superior, satisfactory or unsatisfac-
tory. Major arteries were defined as the left anterior de-
scending (LAD), the left circumflex (LCx), the right
coronary (RCA) and the left main. Left ventricular angio-
grams also were analyzed qualitatively for left ventricular
function. This was done by visual assessment of segmental
wall motion and estimation of ejection fraction.
Lesions were localized to coronary segments according to
the Coronary Artery Surgery Study definition, and the
percent diameter stenosis was estimated from a view dem-
onstrating the most severe narrowing. An attempt was made
to identify possible culprit lesions in each patient using
angiographic criteria for complex coronary stenosis pub-
lished elsewhere (17–23). Clinical and ECG data were not
provided to the consensus panel. For the purpose of this
study, a culprit lesion was defined as a lesion with complex
features suggestive of acute plaque rupture. Six criteria were
used to describe a culprit lesion: intraluminal filling defect
(or thrombus), ulcer with overhanging edges, extraluminal
contrast, dissection or intraluminal flap, multiple irregular-
ities or acute occlusion. In lesions with multiple features, the
predominant feature was used to classify the lesion by
consensus. An occlusion was considered acute if it ended
abruptly, with a squared-off or convex upstream termina-
tion. An occlusion was considered chronic if it tapered
smoothly before the obstruction, or if the exact site of the
occlusion was not well visualized. Ultimately, lesions were
classified as complex or not complex, and occlusions classi-
fied as acute or chronic, based on consensus of the panel
using these criteria as guidelines. Collateral filling to the
distal vessel beyond the culprit lesion was noted as present
or absent. Flow distal to the culprit lesion was visually
estimated by the method used in the Thrombolysis In
Myocardial Infarction (TIMI) trials and graded on a scale of
0 to 3 (24).
Statistical analysis. Patients assigned to the invasive strat-
egy who had a superior or satisfactory angiographic film
were included in this analysis. Baseline characteristics of
these patients were compared with those of the remaining
patients in the invasive strategy to ensure there was no
selection bias. Categorical baseline factors between these
two groups were analyzed using Pearson’s chi-square test,
whereas continuous variables were compared by Student t
test. Pearson’s chi-square test also was employed to compare
the proportion of patients with angiographically normal
coronaries, three-vessel CAD, severe (70%) proximal
stenosis and total (100%) stenosis between those who had
no and 1 culprit lesion. Patients with no culprit lesion, a
single incomplete occlusion, a single abrupt occlusion or
multiple culprit lesions were compared with respect to
treatment with revascularization (coronary angioplasty or
coronary artery bypass grafting [CABG]). These four
groups of patients were analyzed using Pearson’s test. All
analyses were performed using Statistical Analysis Software
version 6.12 (SAS Inc., Cary, North Carolina).
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
CAD  coronary artery disease
ECG  electrocardiogram
LAD  left anterior descending artery
LCx  left circumflex artery
MI  myocardial infarction
NQWMI  non–Q-wave myocardial infarction
RCA  right coronary artery
TIMI  Thrombolysis In Myocardial Infarction
VANQWISH Veterans Affairs Non–Q-Wave
Infarction Strategies in-Hospital study
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RESULTS
Of the 462 patients randomized to the invasive strategy, 442
had the protocol-mandated coronary angiogram. The re-
maining 20 did not complete the angiogram, because of
patient or physician refusal. The core laboratory received
films on 381 patients. Transmittal forms or films were
missing for the remaining patients. A total of 84% of the
films were judged technically superior in quality, 7.9% were
satisfactory and 8.1% were unsatisfactory. Unsatisfactory
films were not analyzed. Thus, this report is based on
findings from 350 patient films.
Clinical, ECG and left ventricular angiographic findings.
Clinical findings for these 350 patients are summarized in
Table 1 and do not differ significantly from the findings in
the 112 patients randomized to this strategy whose films
were not evaluated by the angiographic core laboratory,
except that core laboratory patients were more likely to be
male (98% vs. 93%, p  0.009) and had a slightly lower
incidence of posterior infarction (10% vs. 18%, p  0.030)
compared with those whose films were not evaluated by the
core laboratory. This group predominantly consisted of
older men (98.3% male) with multiple CAD risk factors.
Patients undergoing invasive strategy had a mean ejection
fraction of 41% 13% by core laboratory analysis. Regional
wall motion abnormalities were identified in 258 of the 350
patients (74%). This consisted of akinesia in 29%, hypoki-
nesia in 40% and dyskinesia in 5%.
Coronary angiographic findings. ANGIOGRAPHIC CAUSE
OF MI. The identified angiographic cause of the MI is
shown in Table 2. In all, 270 culprit lesions or acute
occlusions were identified in 221 of the 350 patients. Thus,
in 221 patients (63%), at least one culprit lesion was
identified. A single identifiable culprit lesion was identified
in only 49%. In patients with a single culprit lesion, an
incomplete occlusion was found in 73% and acute total
occlusion was seen in 27%. Multiple culprit lesions or acute
occlusions were seen in 14% of patients. A culprit lesion
could not be identified in 37% of patients. Most of the
patients without an identifiable culprit (84%) had obstruc-
tive lesions (50% stenosis) identified; only 16% had
normal coronaries or non-obstructive CAD (50% steno-
sis).
Identifiable culprit lesions. SINGLE CULPRIT WITH
PATENT INFARCT-RELATED ARTERY. A single culprit lesion
without total occlusion was found in 36% of patients (Table
2). The complex lesion morphologies identified in these
culprit lesions are shown in Table 3. The most common
morphology was ulcer with overhanging edges (42%), fol-
lowed by filling defect (22%). TIMI flow distal to the culprit
lesion was grade 3 in 65%, grade 2 in 21% and grade 1 in
13%. Culprit lesions were identified in the LAD (33%),
LCx (31%) and RCA (36%). These culprit lesions were
located proximal or midportion of the LAD, LCx or RCA
in 72% and in the distal segment or one of the branches in
28%. Collaterals distal to culprit lesions in patent infarct-
related arteries were uncommon, occurring in 16% of
patients.
Table 1. Selected Baseline Characteristics
Characteristics
Core Lab
Angiogram
n  350 (%)
No Core Lab
Angiogram
n  112 (%) p Value
Age (yr) 61.7  9.7 62.4  10.8 0.508
Men 344 (98) 103 (93) 0.009
Current smoker 147 (42) 42 (38) 0.464
History
Family with CAD 132 (38) 43 (39) 0.951
Hypertension 193 (55) 69 (62) 0.234
Dyslipidemia 59 (17) 21 (19) 0.722
Insulin-dependent diabetes 87 (25) 28 (25) 1.000
Peripheral vascular disease 65 (19) 19 (17) 0.838
ECG MI location
(on-site results)
Anterior 161 (46) 43 (40) 0.275
Lateral 185 (53) 65 (60) 0.258
Inferior 122 (35) 44 (40) 0.352
Posterior 35 (10) 20 (18) 0.030
*Continuous variables are compared using the Student t test and expressed as the
mean SD, whereas categorical variables are compared with Pearson’s chi-square test
and represented as the sum and percentage of the total.
CAD  coronary artery disease; ECG  electrocardiogram; MI myocardial
infarction.
Table 2. Angiographic Culprit Lesions Identified as Cause
of MI
n (%)
Patients 350
Culprit lesion identified 221 (63)
Single culprit lesion 173 (49)
Single incomplete occlusion 127 (36)
Single complete occlusion 46 (13)
Multiple culprit lesions 48 (14)
No culprit lesion identified 129 (37)
MI  myocardial infarction; n  number of patients.
Table 3. Stenosis Morphology, TIMI Flow and Collaterals in
Single Nontotal Occlusion
Grade of TIMI Flow
Distal to Culprit Lesion
Collaterals
Distal to
Culprit Lesion
III
(n  83)
II
(n  27)
I
(n  17)
Morphology
Multiple irregularities 11 10 5 6
Filling defect 15 4 9 9
Extraluminal contrast 7 0 1 0
Intraluminal flap 8 3 1 1
Ulcer with
overhanging edges
42 10 1 5
Location of Culprit
(Single Nontotal Occlusion)
LAD
(n  42)
LCx
(n  39)
RCA
(n  46)
Distal/branch 7 18 10
Proximal/mid 35 21 36
LAD  left anterior descending artery; LCx  left circumflex artery; RCA  right
coronary artery; TIMI  Thrombolysis In Myocardial Infarction.
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ACUTE OCCLUSIONS. The cause of the MI was found to be
acute total occlusion in 20% of the patients in this study
(Table 2). In 46 cases, the acute occlusion was isolated and
identified as a single culprit causing the MI. In the other 25
instances, the acute occlusion occurred in combination with
other complex culprit lesions when multiple culprit lesions
were identified (as described later). These occlusions oc-
curred in the LAD in 27%, LCx in 38% and RCA in 35%.
Acute occlusion location was in the proximal or midportion
of the vessel in 70% and branch or distal location in 30%.
Collaterals were common in acutely occluded vessels, oc-
curring in 68%. Overall, 328 total occlusions were identified
in 185 patients, but only 71 of these met angiographic
criteria for acute occlusion.
MULTIPLE CULPRIT LESIONS. The cause of the MI ap-
peared to be due to multiple culprit lesions in 14% of
patients. Forty-four patients had two acute lesions, and four
patients had three angiographic culprit lesions. Five patients
had multiple culprit lesions in the same vessel (such as
proximal LAD and diagonal branch), whereas 43 patients
had culprit lesions in two or more different vascular distri-
butions (RCA and LCx). In these cases, two or more
angiographic locations appear to have led to the MI.
NO IDENTIFIABLE CULPRIT LESION. Coronary angiography
did not delineate the cause of the MI in 37% of the patients.
In general, these patients had severe CAD without any
angiographic culprit lesion. The vast majority of these
patients (84%) had obstructive CAD and 46% had three-
vessel CAD. Thus, although stenoses were identified, the
cause or “culprit” was not identified by angiography. Twenty
(16%) of the 129 patients without an identifiable culprit
lesion had either normal angiograms or non-obstructive
CAD. Interestingly, 50% of these patients had wall motion
abnormalities (nine hypokinesia, one akinesia). Patients
with or without an identifiable culprit lesion did not
differ in terms of three-vessel CAD (39% culprit vs. 46%
no culprit), proximal stenosis location (46% culprit vs.
43% no culprit) or total occlusions (55% culprit vs. 49%
no culprit) (p  NS).
PREVIOUS CORONARY BYPASS SURGERY. Seventy-six (22%)
of patients had undergone previous CABG. A total of 226
bypass grafts were analyzed. Seventy-five percent were
patent and 25% were occluded. In patients with previous
CABG, a culprit lesion was identified in 58%. The culprit
lesion was in a bypass graft in 36 patients and in a native
vessel in 10 patients. Two patients had two culprit lesions
with one in a native vessel and one in a bypass graft. The
most common culprit lesion morphology in bypass grafts
was ulcer with overhanging edges (31%), followed by filling
defect (26%). Only eight abrupt occlusions of bypass grafts
were identified as the culprit lesion.
Revascularization in patients with and without identifi-
able culprit lesions. CORONARY ANGIOPLASTY. Patients
with a single identifiable culprit lesion were more likely to
be treated with coronary angioplasty. In the 127 patients
with a single incomplete occlusion as the culprit lesion, 41%
underwent coronary angioplasty, whereas patients with a
single acute occlusion underwent coronary angioplasty in
28% of cases. Angioplasty was used less frequently in
patients with no identifiable culprit lesion (14%) or multiple
culprit lesions (15%) (p  0.001, single culprit vs. no or
multiple culprits; Fig. 1).
CABG. Patients with multiple culprit lesions were more
likely to be treated with CABG than patients with a single
or no identifiable culprit lesion. Forty-eight patients had
multiple culprit lesions identified, and 56% of these patients
underwent CABG. In contrast, only 17% of patients with
no identifiable culprit lesion had CABG. Patients with
single culprit lesions had intermediate rates of CABG (Fig.
1). Thus, patients with no identifiable culprit lesion had the
lowest rate of revascularization with either coronary angio-
plasty or CABG (31%), whereas patients with multiple
culprit lesions were revascularized most often (71%).
DISCUSSION
This is the first prospective, large-scale detailed coronary
angiographic analysis of contemporary patients with
NQWMI to be published. In this study, angiograms were
analyzed at a central core laboratory, and the focus was to
identify a culprit lesion and assess the severity of disease.
Our findings indicated that NQWMI is not caused entirely
by incomplete occlusion of the infarct-related artery, as has
been previously suggested. A single complex stenosis with-
out occlusion was found in only 36% of patients. A single
acute total occlusion was also uncommon, found in only
13%. Total occlusions were common in this study, but most
appeared angiographically to be chronic. Because 14% of
patients had multiple apparent culprit lesions, a single
identifiable culprit lesion was found in less than one half of
the patients. Many patients, therefore, did not have an
identifiable culprit lesion in this study using predefined
criteria for acute or complex lesions. The majority of
patients without identifiable culprit lesions had severe cor-
onary stenoses, but without angiographic morphologies
indicating acute plaque rupture.
Comparison to previous studies. These findings contrast
with those of previous studies of NQWMI that presumed a
culprit lesion almost always can be identified (12,20,25).
Previous angiographic studies of patients with NQWMI are
case series of patients undergoing angiography at various
time intervals after infarction (12). Most studies have been
retrospective and have had relatively small numbers of
patients. The indication for and timing of the angiogram
vary according to practice patterns. In addition, most
previous studies took place before currently used therapies
for acute ischemic syndromes, including aspirin, heparin,
beta-blockers and calcium channel blockers. In 1986,
DeWood retrospectively analyzed the coronary angiograms
of 341 patients studied within seven days of NQWMI (12).
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The patients were grouped on the basis of the time between
infarction and angiography. The authors found that the
incidence of total occlusion increased over time, from 26%
in the 24-h group to 42% in the 72-h group. Complex
morphology consistent with a culprit lesion was not evalu-
ated. Data such as these led to the notion that NQWMI is
due to incomplete occlusions at risk for progression to total
occlusion.
COMPARISON WITH Q-WAVE INFARCTION AND UNSTABLE
ANGINA. Patients with Q-wave infarction often have an
easily identifiable single culprit lesion in the artery corre-
sponding to ST segment elevation and/or Q waves (1,2,26).
Some of the difference in culprit lesion detection comparing
our study to studies of patients with Q-wave MI may be due
to earlier angiography in the patients with Q-wave MI.
However, even when angiography is delayed after Q-wave
MI (after thrombolysis, for example) the culprit is usually
easily identifiable as a complex plaque in one of the three
coronary territories (6,8). Earlier angiography may have
increased our rate of culprit lesion detection, but our data
contrast with those of previous studies of Q-wave MI where
a clear-cut single culprit is almost always identified
(2,3,5,6,8).
In patients with unstable angina it is often assumed that
a single culprit lesion can be identified with angiography.
Many studies do not include core laboratory analysis or
report the number of patients without a definite culprit
lesion. Strict criteria for culprit lesion morphology often
were not prespecified in these previous studies. Angio-
graphic morphologies consistent with acute plaque rupture
have been studied extensively. Ambrose and colleagues
identified an Ambrose type II lesion (ulcer with overhang-
ing edges) in 70% of patients with unstable angina under-
going angiography (19). This morphology was seen in 35%
of patients with a culprit lesion and in only 23% of the 350
patients undergoing angiography in our study. Culprit
Figure 1. Rates of revascularization with percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG) in patients
with no culprit lesion, one culprit lesion or multiple culprit lesions. Patients with one culprit lesion are divided into two groups: incomplete occlusion or
acute total occlusion. *Single incomplete occlusion vs. no or multiple culprit lesions, p  0.001; **Single incomplete occlusion vs. single acute occlusion,
p  0.128; ***Multiple culprit lesions vs. other groups, p  0.010.
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lesion morphology in NQWMI was assessed in a central
core laboratory in TIMI IIIA, which evaluated the culprit
lesion in 306 patients with unstable angina or NQWMI
within 12 h of enrollment (20). The majority of patients in
this study had unstable angina. A NQWMI was diagnosed
in 32% of patients. A culprit lesion was identified in all of
the 306 patients entered in TIMI IIIA, but complex lesion
morphology was not required for a lesion to be classified as
a culprit. Complex lesion morphology was identified in only
215 (70%) of the patients and two culprit lesions were seen
in 32% of patients in TIMI IIIA. We identified complex
lesion morphology (excluding acute occlusions) in 50% of
patients and two or more culprit lesions in 14%, including
only patients with NQWMI. Core angiographic analyses
from the PRISM-PLUS trial are available for 1,491 patients
with unstable angina (56%) and NQWMI (44%) (27). All
the patients in this trial had an identifiable culprit lesion,
despite the fact that 10% had nonsignificant disease. A
stenosis was classified as the culprit even if no complex
morphologic features were present. A possible or definite
thrombus was seen in 45% of patients in that trial, but other
lesion morphologies were not reported. In a recently re-
ported FRISC II substudy, a culprit lesion was identified by
local reading in 56% of patients with an acute coronary
syndrome, similar to our findings (28).
No or multiple culprit lesions. We do not know why
many patients in this study did not have an identifiable
culprit lesion. Certainly some of the stenoses identified
without complex features were actually culprits, but with so
many obstructive lesions present we cannot assume that all
or even most of these stenoses were culprit lesions. We
speculate that many patients had underlying pathology that
could not be detected with a conventional coronary angio-
gram. Small-vessel occlusion in vessels beyond the resolu-
tion of current angiographic techniques is one possibility.
Also, some large epicardial vessels may have intraluminal or
vessel wall pathology as a stimulus for platelet and thrombus
generation without definite features of plaque rupture an-
giographically. Some culprit lesions may have resolved or
“smoothed out” with antithrombotic therapy before angiog-
raphy. Some patients with NQWMI may not have classic
epicardial vessel plaque rupture and thrombosis but, instead,
have severe ischemic injury based on increased demand in a
setting of limited supply due to severe chronic CAD.
The patients with multiple angiographic culprit lesions
are an interesting subgroup (29). These patients may have
diffuse activation of multiple plaques with multiple plaque
ruptures, similar to what is seen in patients with vasculitis.
Alternatively, an initial plaque rupture may initiate a cascade
of other triggers, leading to a second or third plaque rupture
sequentially. Some complex lesions seen in these patients
may have been the result of previous “old” plaque ruptures
that healed with a complex morphology. Clearly, patients
with NQWMI represent a heterogeneous patient popula-
tion clinically, and the angiographic findings in this study
suggest heterogeneity in the angiographic findings and
probably the underlying pathology.
Implications. Our study included only patients with
NQWMI. We did not assume that a culprit lesion always
would be identified. Our data indicate that an early coronary
angiogram does not always delineate the cause of the MI in
patients with NQWMI. This contrasts sharply with find-
ings from previous studies of patients with Q-wave MI and
studies combining patients with unstable angina and
NQWMI. Our findings are important because most aggres-
sive strategies are predicated on the assumption that a
culprit lesion can be identified and then targeted for
revascularization. Aggressive strategies using coronary an-
gioplasty for acute ischemic syndromes report success rates
based on revascularization of the culprit lesion or infarct-
related artery. In this study of NQWMI, coronary angio-
plasty was performed in 38% of patients when a single
culprit lesion was found and only 14% of patients when no
or multiple culprit lesions were seen. These data suggest
that although the coronary angiogram is still the gold
standard for the identification of coronary artery obstruc-
tion, angiographic findings early after NQWMI often will
fail to identify the cause of the infarction. The results from
the recently reported TACTICS trial are consistent with
our findings (30). This trial compared an early invasive
strategy to conservative therapy in patients treated with
aspirin, heparin and tirofiban. In the invasive arm of this
trial, only 41% of the patients were treated with percutane-
ous intervention. Although no core angiographic laboratory
data are available, this low rate of percutaneous revascular-
ization suggests that a single culprit lesion was not fre-
quently identified.
The present study has several advantages over previous
reports. A common protocol was used prospectively to select
and treat patients using contemporary therapy (e.g., aspirin,
heparin, diltiazem, etc.) Angiograms were mandated by
protocol and done three to seven days after infarction. A
consensus panel of three angiographers who were blind to
clinical data analyzed the angiograms. In contrast to previ-
ous reports, not all total occlusions were assumed to be
culprits and angiographic features of acute occlusion were
required for culprit lesions. Morphologies accepted as mark-
ers of acute plaque rupture and threatened thrombotic
occlusion were prospectively decided upon and included as
potential culprit lesions. Thus, this report involves the
largest group of patients prospectively undergoing a
protocol-mandated coronary angiogram in the era of mod-
ern therapy for acute ischemic syndromes.
Study limitations. Several limitations of this analysis de-
serve attention. First, a general qualitative assessment was
performed. This, however, was done using a consensus
among three experienced angiographers and is in keeping
with other reports. Quantitative computer-assisted angio-
graphic analysis was not performed and would have been
very difficult, considering the severity and complexity of
disease. Second, ECG data that may help determine the
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culprit lesion location were not available to core laboratory
angiographers. Thus, it is possible our assessment of culprit
lesions underestimates their true frequency in these patients.
On the other hand, clinicians who are biased by electrocar-
diographic and clinical information may “overinterpret” the
angiogram and assume a chronic stenosis is an acute lesion.
Third, the time between presentation and coronary angiog-
raphy ranged from three to seven days. Accordingly, it is
assumed that these angiographic findings were present at
the onset of the NQWMI. Fourth, this was a predomi-
nantly male population, so the findings may not apply to
women with NQWMI. Finally, patients had to be clinically
stable for three days before entering this trial; therefore,
patients who died or developed reinfarction, recurrent isch-
emia, heart failure, ventricular tachyarrhythmia or shock
during this early time period were not included.
Conclusions. Coronary angiography early after NQWMI
frequently identifies severe obstructive CAD, but a single
identifiable culprit lesion was identified in 50% of pa-
tients. Multiple culprit lesions were seen in 14% of patients
and an angiographic culprit lesion could not be identified in
more than one third of patients undergoing coronary an-
giography as part of an invasive strategy. These data should
be considered in future studies of revascularization of the
infarct-related artery in patients with NQWMI.
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